Resources for News Media
The NCI press office is the central news contact for all members of the media. The office can assist you in arranging interviews with NCI researchers and in providing accurate and timely cancer research news and information.
For information about NCI's history and current activities, see NCI Overview and Budget and Appropriations.
Connect with Us
Our office hours are Monday through Friday, 9 a.m. to 5 p.m. ET.
NCI's YouTube Channel
Building 31, Room 10A25
31 Center Drive MSC 2580
Bethesda, MD 20892-2580
Recent Interviews from Scientists at NCI
National Cancer Institute director opens up about her own cancer diagnosis
February 15, 2023 | NPR
NPR's Ailsa Chang talks with National Cancer Institute Director Dr. Monica Bertagnolli on Biden's cancer moon shot and her breast cancer diagnosis.
The Cancer Moonshot Enters a New Phase
January 25, 2023 | IEEE Pulse
Moonshot-supported research has made progress in lowering cancer mortality rates, and this new initiative prioritizes diversity in research with a goal of ending cancer as we know it
Drug Approved to Help Young Patients Battle a Rare Cancer
January 2, 2023 | HealthDay
Children and adults with a rare type of soft tissue cancer will now have a new treatment option that could have a big impact. The U.S. Food and Drug Administration has approved the immunotherapy drug atezolizumab (Tecentriq) for use in patients with advanced alveolar soft part sarcoma (ASPS) that has spread to other parts of the body or cannot be removed by surgery.
A new kind of blood test can screen for many cancers — as some pregnant people learn
December 23, 2022 | NPR
The simple blood test looks at DNA that's floating freely in a pregnant person's bloodstream. It searches for bits released by cells in the placenta, which should have the same genetic make-up as the fetus.
Few Americans aware of cancer risks posed by alcohol: study
December 2, 2022 | The Hill
A low number of Americans are aware of the myriad cancer risks posed by alcohol consumption. Just over 30 percent know liquor can increase the risk of certain cancers, while 25 percent said the same about beer and 20 percent about wine, according to a new study from the American Association of Cancer Research (AACR).
US cancer death rates across all age groups continue on downward trend, new study shows
October 27, 2022 | USA Today
Overall U.S. cancer death rates continue to drop among men, women, children, teens and young adults, according to a report released Thursday.
Telehealth For Cancer Care Receives $23 Million Research Funding Boost
August 18, 2022 | Forbes
The National Cancer Institute at the National Institutes of Health (NIH) will award funding to conduct research into the use of telehealth for cancer care by creating four new “Telehealth Research Centers of Excellence.”
Drinking Black Tea May Lower Mortality Risk, Study Suggests
August 29, 2022 | Time
While green tea has a long-standing reputation for health benefits, research has been much more mixed on black tea. One problem, says Maki Inoue-Choi, an epidemiologist at the National Cancer Institute, is that large observational studies on tea and mortality have focused on countries like Japan or China—places where green tea is more popular.
'We still are dying at alarming rates': Black cancer death rates are falling but remain higher than others, study finds
May 19, 2022 | USA Today
Despite declining cancer death rates, Black people still died of cancer at higher rates than any other racial group, a new study shows.
Evidence of Novel Susceptibility Variants for Prostate Cancer and a Multiancestry Polygenic Risk Score Associated with Aggressive Disease in Men of African Ancestry
Article on ScienceDirect - Background: Genetic factors play an important role in prostate cancer (PCa) susceptibility; Objective: To discover common genetic variants contributing to the risk of PCa in men of African ancestry.
White House Fact Sheet: On One Year Anniversary of Reignited Cancer Moonshot, Biden-Harris Administration Announces New Actions to End Cancer as We Know It
One year ago, President Joe Biden and First Lady Jill Biden reignited the Cancer Moonshot, setting an ambitious, achievable goal: to reduce the death rate from cancer by at least 50 percent over the next 25 years, and improve the experience of people and families living with and surviving cancer, ultimately ending cancer as we know it today.
HER2’s Genetic Link to Breast Cancer Spurs Development of New Treatments
HER2 is a gene that has been linked to breast cancer growth. Learn about the development of trastuzumab, a monoclonal antibody that blocks the HER2 protein, and other treatments that have improved survival for women with HER2-positive breast cancer.
Breast Cancer—Patient Version
Breast cancer is the second most common cancer in women after skin cancer. Mammograms can detect breast cancer early, possibly before it has spread. Start here to find information on breast cancer treatment, causes and prevention, screening, research, and statistics.
Uterine Cancer—Patient Version
Uterine cancers can be of two types: endometrial cancer (common) and uterine sarcoma (rare). Endometrial cancer can often be cured. Uterine sarcoma is often more aggressive and harder to treat. Start here to find information on uterine cancer treatment, causes and prevention, screening, research, and statistics.
Cancer Treatment Vaccines
Cancer treatment vaccines treat cancer by strengthening the body’s natural defenses against the cancer. This page covers how cancer treatment vaccines work against cancer, cancers that are treated with them, and the side effects they may cause.
Cancer death rates among Black people declined over time, but remain higher than other racial and ethnic groups
From 1999—2019, US rates of cancer death fell among Black people. Yet, in 2019, their rates remained higher than those of other racial and ethnic groups.
NCI COVID-19 in Cancer Patients Study (NCCAPS)
The NCI COVID-19 in Cancer Patients Study, or NCCAPS, is a natural history study of COVID-19 in people with cancer. The knowledge gained from this study will help doctors better manage treatment for people with cancer and COVID-19 in the future.
Multimedia from NCI
50 Years of Cancer Treatment and Diagnostics
Clinical trials, innovation in research, and technology have improved cancer treatment and diagnostics in public health. Listen to Healthcast’s National Cancer Act podcast series to learn more.
Recent News Releases
Cancer Grand Challenges announces global research funding opportunity with nine new challenges
As part of the Cancer Grand Challenges program, NCI and Cancer Research UK have announced nine new research challenges to tackle profound problems in cancer research.
NCI clinical trial leads to atezolizumab approval for advanced alveolar soft part sarcoma
A clinical trial led by NCI has resulted in FDA approval of the immunotherapy drug atezolizumab (Tecentriq) to treat advanced alveolar soft part sarcoma.
Statement from Monica M. Bertagnolli, M.D., Director, National Cancer Institute, National Institutes of Health
A statement from the National Cancer Institute by NCI Director Monica M. Bertagnolli, M.D., about her recent diagnosis with early breast cancer.